2007-2011年医药商业上市公司经济运行情况分析

目的：评价中国医药商业上市公司的经济运行情况。方法：对9家医药商业上市公司2007—2011年的财务数据进行分析计算，综合运用比较分析法、比率分析法、趋势分析法从企业的偿债能力、营运能力、盈利能力、发展能力、市场价值5个方面对医药上市公司经济运行情况进行分析。结果：医药商业上市公司的短期偿债能力较弱，长期偿债能力较强；营运能力资金方面较弱，资产方面较强；盈利能力较弱；发展能力较强；市场价值逐步提高。结论：医药商业上市公司经济运行情况基本处于一个合理、健康、良好的状态。

Analysis of the Economic Operation of Listed Companies of the Pharmaceutical Business during 2007--2011

OBJECTIVE： To evalute the economic operation of listed companies of the pharmaceutical business in China. METHODS： The financial data of 9 listed companies of the pharmaceutical business during 2007--2011 were calculated and ana- lyzed. By using comparative analysis, ratio analysis, trend analysis, the economic operation of listed companies of the pharmaceuti- cal business were analyzed in 5 aspects of debt paying ability, operation ability, profitability, development ability and market val- ue. RESULTS ： The listed companies of the pharmaceutical business showed weak debt paying ability but strong long-term debt pay- ing ability; weak operation ability in field of funding but strong operation ability in field of assets; weak profitability; strong devel- opment ability; gradual improvement of market value. CONCLUSIONS： The economic operation of listed enterprises of the phar- maceutical business is in a reasonable, good and health status.